Evaluation of the rodent Hershberger assay using three reference endocrine disrupters (androgen and antiandrogens)

Reproductive Toxicology

Volumn 18, Issue 1, 2004, Pages 63-73

  Kennel, Philippe F ^a   Pallen, Catherine T ^a   Bars, Rémi G ^a  

^a BAYER AG   (Germany)

Author keywords

17 Methyltestosterone; Endocrine effects; Finasteride; Hershberger assay; Procymidone; Sex accessory tissues

Indexed keywords

FINASTERIDE; LUTEINIZING HORMONE; METHYLTESTOSTERONE; PROCYMIDONE; TESTOSTERONE; TESTOSTERONE PROPIONATE;

ADRENAL GLAND; ANDROGEN RELEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CASTRATION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; EVALUATION; HERSHBERGER ASSAY; IMMATURITY; KIDNEY MASS; LIVER WEIGHT; LUTEINIZING HORMONE BLOOD LEVEL; MALE; MAXIMUM ALLOWABLE CONCENTRATION; NONHUMAN; PERINATAL PERIOD; RAT; REPRODUCTIVE TOXICITY; STATISTICAL SIGNIFICANCE; TESTIS WEIGHT; TESTOSTERONE BLOOD LEVEL; TOXICITY TESTING;

RODENTIA;

EID: 0842328573     PISSN: 08906238     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.reprotox.2003.10.012     Document Type: Article

References (44)

1. Colborn T., Vom Saal F.S., Sato A.M. Developmental effects of endocrine-disrupting chemicals in wildlife and humans. Environ. Health Perspect. 101:1993;378-384.
2. Crisp T.M., Clegg E.D., Cooper R.L.et al. Environmental endocrine disruption: an effects assessment and analysis. Environ. Health Perspect. 106(Suppl. 1):1998;11-56.
3. Gray L.E. Jr. Xenoendocrine disrupters: laboratory studies on male reproductive effects. Toxicol. Lett. 102/103:1998;331-335.
4. Kelce W.R., Wilson F.M. Environmental antiandrogens: developmental effects, molecular mechanisms, and clinical implications. J. Mol Med. 75:1997;198-207.
5. McLachlan J.A. Functional toxicology: a new approach to detect functionally active xenobiotics. Environ. Health Perspect. 101:1993;582-587.
6. McLachlan J.A., Korach K.S. Estrogens in the environmental global health implications. Environ. Health Perspect. 103:1995;3-4.
7. Sharpe R.M. Hormones and testis development and the possible adverse effects of environmental chemicals. Toxicol. Lett. 120:2001;221-232.
8. Danzo B.J. The effects of environmental hormones on reproduction. Cell Mol. Life Sci. 54:1998;1249-1264.
9. EPA. Endocrine Disruptor Screening and Testing Advisory Committee (EDSTAC). Final report EPA/743/R-98/003; 1998.
10. Callow R.K., Deanesly R. Effect of androsterone and of male hormone concentrate on the accessory reproductive organs of castrated rats, mice and guinea-pigs. Biochem. J. 29:1935;1424-1445.
11. Korenchevsky V. The assay of testicular hormone preparations. Biochem. J. 26:1932;413-422.
12. Korenchevsky V., Dennison M., Schalit R. The response of castrated male rats to the injection of the testicular hormone. Biochem. J. 26:1932;1306-1314.
13. Eisenberg E., Gordan G.S., Elliott H.M. Testosterone and tissue respiration of the castrate male rat with a possible test for myotrophic activity. Endocrincology. 45:1949;113-119.
14. Eisenberg E., Gordan G.S. The levator ani muscle of the rat as an index of myotrophic activity of steroidal hormones. J Pharmacol Exp Therap. 99:1950;38-44.
15. Hershberger L.G., Shipley E.G., Meyer R.K. Myotrophic activity of 19-nortestosterone and other steroids determined by modified levator ani muscle methods. Proc. Soc. Exp. Biol. Med. 83:1953;175-180.
16. Dorfman RI. Androgens and anabolic agents. In: Dorfman RI, editor. Methods in hormone research. vol. IIA. New York: Academic Press; 1969. p. 151-220.
17. Dorfman RI. Antiandrogens. In: Dorfman RI, editor. Methods in hormone research. vol. IIA. New York: Academic Press; 1969. p. 221-49.
18. Kelce W.R., Lambright C.R., Gray L.E., Roberts K.P. Vinclozolin and p,p′-DDE alter androgen-dependent gene expression: in vivo confirmation of an androgen receptor-mediated mechanism. Toxicol. Appl. Pharmacol. 142:1997;192-200.
19. Raynaud J.P., Bouton M.M., Moguilewsky M.et al. Steroid hormone receptors and pharmacology. J. Steroid Biochem. 12:1980;143-157.
20. Rittmaster R.S., Magor K.E., Manning A.P., Norman R.W., Lazier C.B. Differential effect of 5α-reductase inhibition and castration on androgen-regulated gene expression in rat prostate. Mol. Endocrinol. 5:1991;1023-1029.
21. Shao T.C., Kong A., Cunningham G.H. Effects of 4-MAPC, a 5α-reductase inhibitor, and cyproterone acetate on regrowth of the rat ventral prostate. Prostate. 24:1994;212-220.
22. Snyder B.W., Winneker R.C., Batzold F.H. Endocrine profile of WIN 49596 in the rat: a novel androgen receptor antagonist. J. Steroid Biochem. 33:1989;1127-1132.
23. Wakeling A.E., Furr B.J.A., Glen A.T., Hughes L.R. Receptor binding and biological activity of steroidal and nonsteroidal antiandrogens. J. Steroid Biochem. 15:1981;355-359.
24. Ashby J., Lefevre P.A. Preliminary evaluation of the major protocol variables for the Hershberger castrated male rat assay for the detection of androgens, antiandrogens, and metabolic modulators. Reg. Toxicol. Pharmacol. 31:2000;92-105.
25. Yamada T., Kunimatsu T., Sako H.et al. Comparative evaluation of a 5-day Hershberger assay utilizing mature male rats and a pubertal male assay for detection of flutamide's antiandrogenic activity. Toxicol Sci. 53:2000;289-296.
26. Yamasaki K., Sawaki M., Takatsuki M. Strain sensitivity differences in the Hershberger assay. Reprod. Toxicol. 15:2001;437-440.
27. O'Connor J.C., Frame S.R., Davis L.G., Cook J.C. Detection of the environmental antiandrogen p,p′-DDE in CD and Long-Evans rats using a Tier I screening battery and a Hershberger assay. Toxicol. Sci. 51:1999;44-53.
28. Peets E.A., Henson M.F., Neri H. On the mechanism of the antiandrogenic action of flutamide (α-α-α-trifiuoro-2-methyl-4′-nitro- m-propionotoluidide) in the rat. Endocrinology. 94:1973;407-532.
29. Yamada T., Sunami O., Kunimatsu T.et al. Dissection and weighing of accessory sex glands after formalin fixation, and a 5-day assay using young mature rats are reliable and feasible in the Hershberger assay. Toxicology. 162:2001;103-119.
30. OECD, Organization for Economic Cooperation and Development. 2nd meeting of the Validation Management Group on screening and testing for endocrine disrupters (mammalian effects). Paris; 2000.
31. OECD, Organization for Economic Cooperation and Development. Proceedings of the third meeting of the Validation Management Group for the screening and testing of endocrine disrupters (mammalian effects). Joint meeting of the chemicals committee and the working party on chemicals, pesticides and biotechnology. Paris; 2001.
32. OECD, Organization for Economic Cooperation and Development. Final OECD report of the work towards the validation of the rat Hershberger assay: phase-1, androgenic response to testosterone propionate, and anti-androgenic effects of flutamide. ENV/JM/TG/EDTA(2002)1/REV2. Paris; 2002.
33. OECD Series on Principles of Good Laboratory Practice and Compliance Monitoring, No. 1. Paris: Organization for Economic Cooperation and Development; 1998.
34. Eryl S. The analysis of organ weight data. Toxicology. 8:1977;13-22.
35. Gray L.E. Jr., Kelce W.R., Wiese T.et al. Endocrine screening methods workshop report: detection of estrogenic and androgenic hormonal and antihormonal activity for chemicals that act via receptor or steroidogenic enzyme mechanisms. Reprod. Toxicol. 11:1997;719-750.
36. Blohm T.R., Laughlin M.E., Benson H.D.et al. Pharmacological induction of 5α-reductase deficiency in the rat: separation of testosterone- mediated and 5α-dihydrotestosterone-mediated effects. Endocrinology. 119:1986;959-966.
37. Nellemann C., Dalgaard M., Lam H.R., Vinggaard A.M. The combined effects of vinclozolin and procymidone do not deviate from expected additivity in vitro and in vivo. Toxicol Sci. 71:2003;251-262.
38. Yamasaki K., Takeyoshi M., Sawaki M., Imatanaka N., Shinoda K., Takatsuki M. Immature rat uterotrophic assay of 18 chemicals and Hershberger assay of 30 chemicals. Toxicology. 183:2003;93-115.
39. Sunami O., Kunimatsu T., Yamada T.et al. Evaluation of a 5-day Hershberger assay using young mature male rats: methyltestosterone and p,p′-DDE, but not fenitrothion, exhibited androgenic or antiandrogenic activity in vivo. J. Toxicol. Sci. 25:2000;403-415.
40. Andrews P., Freyberger A., Hartmann E.et al. Feasibility and potential gains of enhancing the subacute rat study protocol (OECD test guideline no. 407) by additional parameters selected to determine endocrine modulation. A pre-validation study to determine endocrine-mediated effects of the antiandrogenic drug flutamide. Arch. Toxicol. 75:2001;65-73.
41. Hosokawa S., Murakami M., Ineyama M.et al. The affinity of procymidone to androgen receptor in rats and mice. J. Toxicol. Sci. 18:1993;83-93.
42. Cook J.C., Mulline L.S., Frame S.R., Biegel L.B. Investigation of a mechanism for Leydig cell tumorigenesis by linuron in rats. Toxicol. Appl. Pharmacol. 119:1993;195-204.
43. Viguier-Martinez M.C., Hochereau de Reviers M.T., Barenton B., Perreau C. Effect of a non-steroidal antiandrogen, flutamide, on the hypothalamo- pituitary axis, genital tract and testis in immature rats: endocrinological and histological data. Acta Endocrinol. 102:1983;299-306.
44. Viguier-Martinez M.C., Hochereau de Reviers M.T., Barenton B., Perreau C. Endocrinological and histological changes induced by flutamide treatment on the hypothalamo-hypophyseal testicular axis of the adult male rat and their incidences on fertility. Acta Endocrinol. 104:1983;246-252.